Navigation Links
Study shows link between influenza virus and fever
Date:11/16/2009

This release is available in German.

Viruses are microscopically sized parasites. They plant their genes in the cells of their victim in order to 'reprogram' them. The infected cells then no longer produce what they need to live, making lots of new viruses instead.

Luckily, in most cases this hostile takeover does not go unnoticed. This is ensured by the cells' own sensors that recognise alien genetic material. One of them is RIG-I. When RIG-I encounters virus genes, it ensures that the body releases interferon. The interferon then in turn puts killer cells on combat standby, which then destroy the infected cells.

Yet this is only part of the truth. 'According to our results RIG-I appears to play a far more prominent role in the defence against viruses than was previously thought,' Dr. Jrgen Ruland from the University Hospital Rechts der Isar at the Technical University of Munich explains. As a result, many virus infections are accompanied by a high temperature. That is also what happens with influenza, for example. This symptom cannot be explained by interferon release alone.

In most cases it is cytokines which trigger the fever. 'We have now been able to show, for the first time, that RIG-I also cranks up the production of a central cytokine in the case of a virus infection,' Dr. Hendrik Poeck explains. He and his colleagues Dr. Michael Bscheider and Dr. Olaf Gro are the primary authors of the study. This is a reference to interleukin 1, probably the most important cytokine known today.

Do cytokines cause more severe courses of a disease?

When RIG-I comes into contact with a virus gene, it does two things. On the one hand, it ensures that certain immune cells produce pro-interleukin, the precursor of interleukin 1, en masse. At the same time it activates an enzyme via a complicated signalling pathway which transforms pro-interleukin into interleukin 1. 'This interleukin 1 then ensures that the typical symptoms of a virus infection such as fever or shivering occur,' Professor Veit Hornung from the Bonn University Clinic explains.

As yet the researchers do not know how important this newly discovered immune mechanism is for the successful defence against the virus. The release of interleukin may also have negative consequences. 'There is the hypothesis that an overproduction of cytokines may lead to extremely severe courses of virus diseases,' Professor Gunther Hartmann says. Medicines that prevent such a 'cytokine storm' may therefore alleviate the progress of the disease.


'/>"/>

Contact: Veit Hornung
veit.hornung@uni-bonn.de
49-022-828-712-170
University of Bonn
Source:Eurekalert

Related biology news :

1. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
2. A study by the MUHC and McGill University opens a new door to understanding cancer
3. Study begins to reveal clues to the cause and progression of sepsis
4. Clones on task serve greater good, evolutionary study shows
5. New study warns limited carbon market puts 20 percent of tropical forest at risk
6. New study examines how rearing environment can alter navigation
7. Study links cat disease to flame retardants in furniture and to pet food
8. New continent and species discovered in Atlantic study
9. Study shows link between alcohol consumption and hiv disease progression
10. Feeling hot, hot, hot: New study suggests ways to control fever-induced seizures
11. Study finds environmental tests help predict hospital-acquired Legionnaires disease risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... , January 12, 2017 A new report by Allied ... that the global biometric technology market is expected to generate revenue of $10.72 billion ... Continue Reading ... Allied Market Research ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
(Date:1/11/2017)... , Jan. 11, 2017  Michael Johnson, co-founder of Visikol ... Capital Group, Inc., has been named to the elite "Forbes 30 ...  was one of 600 people in 20 fields nationwide to be ... of the 15,000 applicants were selected. ... He is currently a PhD candidate at Rutgers ...
(Date:1/6/2017)... BOULDER, Colo. , Jan. 5, 2017 /PRNewswire/ ... join the "Digital Life Alliance" established by iCarbonX, ... in 2015 to build a "Global Digital Health ... based on a combination of individual,s biological, behavioral ... Under the agreement between the companies, SomaLogic will ...
Breaking Biology News(10 mins):
(Date:1/11/2017)... ... January 11, 2017 , ... For many fledging ... navigating the challenges young businesses face. With the second installment of Quorum’s newest ... of Geoff DiMasi, Founder and Principal of interactive design agency, P’unk Ave. ...
(Date:1/11/2017)... ... 11, 2017 , ... Back pain relief technology is now available without a ... positive back pain relief for WAR members. , This spinal restoration platform boasts utilization ... changing for millions suffering from chronic back pain. , What A Relief ...
(Date:1/11/2017)... England , PITTSBURGH and BENGALURU, ... -- Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE ... Food and Drug Administration (FDA) has accepted Mylan,s biologics ... for filing through the 351(k) pathway. This product is ... to treat certain HER2-positive breast cancers. The anticipated FDA ...
(Date:1/11/2017)... 11, 2017  GenVec, Inc. (NASDAQ: ... today that its chief scientific officer, Douglas ...  "AdenoVerse™ platform for translational development of innovative gene ... the upcoming Phacilitate Cell & Gene Therapy World ... Florida.  Dr. Brough,s presentation will highlight the utility ...
Breaking Biology Technology: